Announcements Trials
Browse Landscape

Phase

Phase NA 18Phase 3 2Phase 2 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Other 1Head & Neck 1

Conditions

Pulmonary Disease, Chronic Obstructive 1Mucositis 1Head and Neck Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Abnormalities, Radiation-Induced 1

Interventions

Cisplatin 186Carboplatin 181Paclitaxel 175Docetaxel 144Cyclophosphamide 129Dexamethasone 117pembrolizumab 106Doxorubicin 103Bevacizumab 103Gemcitabine 102Rituximab 96Prednisone 87Fluorouracil 86Pemetrexed 81Radiotherapy 77Vincristine 71Etoposide 71Capecitabine 69Nivolumab 68Trastuzumab 67Leucovorin 64Cytarabine 57Methotrexate 52Oxaliplatin 49atezolizumab 47Lenalidomide 43Ipilimumab 40Filgrastim 40Bortezomib 39Sorafenib 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Has results × Educational Status × Clear all
NCT02887521 2025-02-03

Pulmonary Rehabilitation Before Lung Cancer Resection

Alliance for Clinical Trials in Oncology

Phase 3 Terminated
9 enrolled 6 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Pulmonary Disease, Chronic Obstructive

NCT02480114 2021-02-18

Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy

Vanderbilt-Ingram Cancer Center

Phase 3 Completed
79 enrolled 8 charts
Head & NeckOther

Abnormalities, Radiation-Induced, Head and Neck Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡